Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Therapeutic Advances In Childhood Leukemia Consortium

Clinical trials sponsored by Therapeutic Advances In Childhood Leukemia Consortium, explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Completed 2

New drug combination targets rare childhood leukemia that resists standard treatment

Disease control Not yet recruiting

This trial tests whether adding the drug revumenib to standard chemotherapy (fludarabine and cytarabine) can help children and young adults with a rare form of acute myeloid leukemia (AML) that has come back or not responded to treatment. The study enrolls up to 27 participants a…

Phase: PHASE2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC